Assessing acute systemic effects of an inhaled drug with serial echocardiography: a placebo-controlled comparison of inhaled and intravenous dihydroergotamine

OBJECTIVE: MAP0004 is an investigational product which delivers dihydroergotamine (DHE) through the lung via a breath-synchronized metered dose inhaler. The objective of this study was to compare the acute effects of orally inhaled and intravenous (IV) DHE to placebo on maximum change and area under...

Descripción completa

Detalles Bibliográficos
Autores principales: Noveck, Robert J, Douglas, Pamela S, Chow, Shein-Chung, Mangum, Barry, Kori, Shashidhar, Kellerman, Donald J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728267/
https://www.ncbi.nlm.nih.gov/pubmed/23926420
http://dx.doi.org/10.2147/DDDT.S44093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728267/
https://www.ncbi.nlm.nih.gov/pubmed/23926420
http://dx.doi.org/10.2147/DDDT.S44093

Ejemplares similares